Back
Ultragenyx Pharmaceutical Stock Predictions
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
41.11
Seasonality Move:
12.29%
7 Day Trial
ALL ACCESS PASS
$
7
Ultragenyx Pharmaceutical Stock Forecast
- Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 9.9% based on the past 10 years of stock performance.
- Ultragenyx Pharmaceutical has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Ultragenyx Pharmaceutical Stock Undervalued?
The current Ultragenyx Pharmaceutical [RARE] share price is $40.97. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ultragenyx Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 9.9% based on the past 10 years of stock performance.
Ultragenyx Pharmaceutical Stock Rating
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical overpriced?
- Ultragenyx Pharmaceutical has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Ultragenyx Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ultragenyx.com
52-Week Data
52-Week High:
54.98
52-Week Low:
31.52
Prediction Charts
Market Cap:
3.41B
Price in USD:
40.97
Volume:
558.17K
Beta:
1.11
Technical Analysis
SMA50:
45.82
SMA100:
46.39
SMA200:
42.07
52-Wk Change:
-13.01%
Stock Predictions
-
Is Ultragenyx Pharmaceutical stock public?
Yes, Ultragenyx Pharmaceutical is a publicly traded company. -
What is the Ultragenyx Pharmaceutical stock quote today?
The Ultragenyx Pharmaceutical stock price is 40.97 USD today. -
How to buy Ultragenyx Pharmaceutical stock online?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-26 | 44.16 | 44.24 | 44.58 | 43.71 |
Apr-29 | 44.52 | 44.02 | 45.36 | 43.92 |
Apr-30 | 43.58 | 42.53 | 44.32 | 42.51 |
May-1 | 42.61 | 43.30 | 44.12 | 42.25 |
May-2 | 43.66 | 43.21 | 44.02 | 42.68 |
May-3 | 44.88 | 42.75 | 46.01 | 42.68 |
May-6 | 42.77 | 43.01 | 43.12 | 41.81 |
May-7 | 43.21 | 41.94 | 43.32 | 41.48 |
May-8 | 41.52 | 41.56 | 42.09 | 41.00 |
May-9 | 41.83 | 41.19 | 42.08 | 41.06 |
May-10 | 41.54 | 40.90 | 41.56 | 40.26 |
May-13 | 40.99 | 40.96 | 41.97 | 40.59 |
May-14 | 41.58 | 40.97 | 41.77 | 40.59 |
May-15 | 41.50 | 41.12 | 41.78 | 41.04 |
Ultragenyx Pharmaceutical Earnings
Ultragenyx Pharmaceutical Earnings Report: Per Share Ultragenyx Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ultragenyx Pharmaceutical Forecast Revenue Growth
Ultragenyx Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Ultragenyx Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.